Clinical Trials
2 trialsNCT03736564 2025-04-30
Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia
Mayo Clinic
Phase 1/2 Completed
NCT01748812 2018-07-05
Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated